We continue to monitor COVID-19, flu and other respiratory viruses in our communities. Read the most current information about prevention, testing and where to go if you're sick.

COVID-19 Information

Young Athlete Center Bridge Program

This is a workout class designed to target muscle groups commonly associated with injury and train neuromuscular responses to coordinate movement and strengthen in proper alignment. This class is led by expert physical therapists and athletic trainers from the Young Athlete Center.

 

Read more

Patient and Visitor Information

Being with your loved ones while they are in the hospital is important to their healing and overall wellbeing, and we are happy to welcome you to Missouri Baptist Medical Center.

Read more

Minimally Invasive Heart Surgery Helps Tom Return to the Basketball Court

Tom Caspari thought he was too healthy to have a heart attack.

Read more

Dr. Stewart Gets a “Second Chance at Life” After Heart Attack

Todd Stewart, MD, is no stranger to critically ill patients and life-saving procedures. As a spinal neurosurgeon and chief of neurosurgery at Missouri Baptist Medical Center, it’s all in a day’s work. But it came as a shock when he suffered a life-threatening heart attack last year.

Read more

Sarah & Andrew Navigate the NICU After Birth of Twin Boys

Sarah and Andrew Sapperstein were looking forward to being parents and were overjoyed and shocked to discover that they were having twins. As the months passed, Sarah's pregnancy was going smoothly, and they planned to welcome their babies by cesarean section (C-section) at 38 weeks.

Read more
135678910Last

Related Content

MoBap Offers a New FDA-Approved Treatment for People With Advanced Prostate Cancer
Elizabeth
/ Categories: Cancer, Innovations in Care

MoBap Offers a New FDA-Approved Treatment for People With Advanced Prostate Cancer

Prostate cancer is the second leading cause of cancer death in American men, with one in eight males diagnosed in their lifetime.

On March 23, 2022, prostate cancer treatment for those with advanced disease took a step forward with the FDA approving the first targeted therapy for the treatment of progressive, PSMA-positive prostate cancer that has spread or metastasized to other parts of the body.

Vincent Joe, MD, a radiation oncologist on staff at Missouri Baptist Medical Center, explained that the new medication is a type of precision radiotherapy that targets a specific protein on the prostate cancer cells called prostate-specific membrane antigen, or PSMA. When it attaches, the medicine delivers a concentrated form of radiotherapy directly to the cancer cells no matter where they are in the body.

"This therapy is designed for those whose cancer isn't responding to standard treatment options like chemotherapy or anti-testosterone hormone treatment. This new therapy has been shown to extend the life of people with terminal prostate cancer and slow down cancer's spread," Dr. Joe said.

For patients, the first step is to have a PSMA positron emission tomography (PET) scan. This test can tell doctors if the prostate cancer has spread to other parts of the body, as well as help to determine their
eligibility for the new drug.

Dr. Joe added that if a patient qualifies for the new therapy, it's given through an IV infusion. "Patients receive an infusion every six weeks for a total of six infusions over 30 weeks. In between treatments, we check blood work to make sure they are tolerating the medication and can modify the dosage if necessary."

Missouri Baptist Medical Center is one of three sites in Missouri that is currently offering this treatment.

"While this treatment is not a cure, it is a very promising therapy for patients who have exhausted other options," Dr. Joe said.

For more information about this treatment, call: 314-996-5199.

 

Print
5777 Rate this article:
No rating

Find a Doctor or Make an Appointment

Our new search tool will help you choose a doctor or health care provider that is best for you or your family.

Search Now